Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Tangible Net Worth Ratio

Latest as of March 2026: 93.1%

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd tangible net worth ratio. Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Tangible Net Worth Ratio of 93.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥110.68 Million) from net assets (CN¥1.60 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 301126 net asset quality index to measure how much of total assets are equity-financed.

Tangible NW Ratio

93.1%
Tangible equity / total equity

Net Assets (Equity)

CN¥1.60 Billion
CNY

Intangible Assets

CN¥110.68 Million
Goodwill, patents, brand value

Total Assets

CN¥6.39 Billion
CNY

Tangible Net Worth Ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)

Tangible net worth ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025. This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 93.1%, reflecting net assets of CN¥1.60 Billion with intangible assets of CN¥110.68 Million CNY. See Hunan Dajiaweikang Pharmaceutical Indust (301126) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Tangible Net Worth Ratio by Year (2019–2025)

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd tangible net worth ratio by year from 2019 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Hunan Dajiaweikang Pharmaceutical Indust market cap and net worth.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 92.9% CN¥1.59 Billion CN¥112.49 Million CN¥6.34 Billion ▲ +0.3 pp
2024 92.7% CN¥1.85 Billion CN¥135.72 Million CN¥6.18 Billion ▲ +0.4 pp
2023 92.2% CN¥1.78 Billion CN¥138.17 Million CN¥5.28 Billion ▼ -2.1 pp
2022 94.3% CN¥1.82 Billion CN¥103.55 Million CN¥3.93 Billion ▼ -4.2 pp
2021 98.5% CN¥1.68 Billion CN¥25.83 Million CN¥2.99 Billion ▲ +1.0 pp
2020 97.5% CN¥1.04 Billion CN¥26.25 Million CN¥2.20 Billion ▲ +0.2 pp
2019 97.2% CN¥977.24 Million CN¥27.02 Million CN¥2.02 Billion —
pp = percentage points